[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54297]], camposKey:0304-3835 2020-01-01 A double safety lock tumor-specific device for suicide gene therapy in breast cancer4353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41754]], camposKey:1525-7797 2019-01-01 Self-Assembling ELR-Based Nanoparticles as Smart Drug-Delivery Systems Modulating Cellular Growth via Akt19962007, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46969]], camposKey:1932-6203 2019-01-01 Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39823]], camposKey:0963-9969 2018-01-01 A different approach for the analysis of grapes: Using the skin as sensing element544550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10900]], camposKey:1088-4246 2014-01-01 Electronic tongue formed by sensors and biosensors containing phthalocyanines as electron mediators. Application to the analysis of red grapes7686, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35043]], camposKey:0340-7004 2013-01-01 In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours541551, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10908]], camposKey:0013-4686 2012-01-01 Multisensor system based on bisphthalocyanine nanowires for the detection of antioxidants8894, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38513]], camposKey:1573-4064 2012-01-01 Transient Injury-Dependent Up-Regulation of CD105 and its Specific Targeting with an Anti-Vascular Anti-Mouse Endoglin-Nigrin b Immunotoxin9961002, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41755]], camposKey:0167-7659 2007-12-01 On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing737747, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35041]], camposKey:0304-3835 2007-01-01 Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b7380, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41756]], camposKey:0008-5472 2006-01-01 Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy33863391, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41757]], camposKey:1568-0096 2005-11-01 Cellular and molecular surrogate markers to monitor targeted and non-targeted antiangiogenic drug activity and determine optimal biologic dose551559, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41758]], camposKey:0960-9776 2005-01-01 Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy466479, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38515]], camposKey:1573-4064 2005-01-01 Cytotoxicity of an ebulin l-anti-human CD105 immunotoxin on mouse fibroblasts (L929) and rat myoblasts (L6E9) cells expressing human CD105.6570, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35042]], camposKey:0041-008X 2005-01-01 Specific dose-dependent damage of Lieberkuhn crypts promoted by large doses of type 2 ribosome-inactivating protein nigrin b intravenous injection to mice138146, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38516]], camposKey:0145-5680 2003-01-01 Evidence for distinct cellular internalization pathways of ricin and nigrin b.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6943]], camposKey:0145-5680 2003-01-01 Non-toxic type 2 ribosome-inactivating proteins (RIPs) from Sambucus: Occurrence, cellular and molecular activities and potential uses537545, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9964]], camposKey:0304-3835 2002-01-01 Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin 12935, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38512]], camposKey:0304-3835 2001-01-01 Sensitivity of cancer cell lines to the novel non-toxic type 2 ribosome-inactivating protein nigrin b163169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41759]], camposKey:0021-9258 1998-01-01 Inability of the acidic fibroblast growth factor mutant K132E to stimulate DNA synthesis after translocation into cells1116411172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41760]], camposKey:0950-9232 1997-01-01 Effect of mutation of cytoplasmic receptor domain and of genistein on transport of acidic fibroblast growth factor into cells525536, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41761]], camposKey:0145-5680 1996-01-01 Differential sensitivity of HELA cells to the type 2 ribosome-inactivating proteins ebulin l, nigrin b and nigrin f as compared with ricin.473476, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8892]], camposKey:0145-5680 1996-01-01 Recent advances in the uses and applications of ribosome-inactivating proteins from plants461471, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41762]], camposKey:0270-7306 1996-01-01 Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization270280, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41763]], camposKey:0021-9258 1995-12-22 Translocation to cytosol of exogenous, CAAX-tagged acidic fibroblast growth factor3068030685, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6947]], camposKey:0145-5680 1995-01-01 A new procedure for the preparation of highly-active melonin from the dry seeds of cucumis-melo L279287, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6934]], camposKey:0032-0935 1994-01-01 Cusativin, a new cytidine-specific ribonuclease accumulated in seeds of Cucumis sativus L.328338, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8884]], camposKey:0022-0957 1994-01-01 Elderberry (sambucus-nigra l) seed proteins inhibit protein-synthesis and display strong immunoreactivity with rabbit polyclonal antibodies raised against the type-2 ribosome-inactivating protein nigrin-b513516, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6929]], camposKey:0032-0935 1994-01-01 Isolation and characterization of two new N-glycosidase type-1 ribosome-inactivating proteins, unrelated in amino-acid sequence, from Petrocoptis species487491, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6933]], camposKey:0031-9317 1993-01-01 A Cucumis sativus cell-free translation system: preparation, optimization and sensitivity to some antibiotics and ribosome inactivating proteins549556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41764]], camposKey:0168-9452 1993-01-01 Development of a cell-free translation system from Cucumis melo: preparation, optimization and evaluation of sensitivity to some translational inhibitors127134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=795]], camposKey:0021-9258 1993-01-01 Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves.1819518199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=794]], camposKey:0167-4412 1993-01-01 Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark ofSambucus nigra L.11811186, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6927]], camposKey:0145-5680 1993-01-01 Messenger-dependent action of the pokeweed antiviral protein and fusidic acid on in-vitro vicia-sativa l translation333337, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8880]], camposKey:0145-5680 1993-01-01 Screening survey of several plant-species in search for ribosome-inactivating protein-like activities885895, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6925]], camposKey:0145-5680 1992-01-01 Effect of fusidic acid on protein-phosphorylation in several eukaryotic cell-free translation systems171174, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6924]], camposKey:0031-9422 1992-01-01 Fusidic acid-dependent wheat germ ribosomal complexes require unphosphorylated elongation factor 25557, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41765]], camposKey:0030-3747 1992-01-01 Intraocular irrigating solutions and vitrectomy-related changes (In protein, lactic and ascorbic acid) in rabbit vitreous6167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6948]], camposKey:0032-0935 1992-01-01 Isolation and partial characterization of a new ribosome-inactivating protein from Petrocoptis glaucifolia (Lag.) Boiss532540, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6928]], camposKey:0022-0957 1992-01-01 Preparation and Optimization of a Cell-free Translation System from Vicia sativa Germ Lacking Ribosome-inactivating Protein Activity729737, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38520]], camposKey:0145-5680 1992-01-01 Presence of single-chain ribosome-inactivating protein-like activities in several plant species.803812, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6926]], camposKey:0340-5761 1991-01-01 Changes in sensitivity of in vitro rat brain protein synthesis to the acute action of ethanol and isopropanol as a consequence of the long-term ingestion of isopropanol500504, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6935]], camposKey:0006-3592 1991-01-01 Effect of continued exposition to ethanol on activity of the ammonium and fructose transport systems in Saccharomyces cerevisiae var. ellipsoideus389391, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6940]], camposKey:0302-8933 1991-01-01 Effect of l-azetidine 2-carboxilic acid on the activity of the general amino-acid permease from Saccharomyces cerevisiae var. ellipsoideus320324, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6919]], camposKey:0145-5680 1991-01-01 Effect of long-term n-butanol ingestion on rat-brain polypeptide-synthesis directed by endogenous messengers671677, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6932]], camposKey:0031-9422 1991-01-01 Protein phosphorylation in a cell-free translation system from Vicia sativa31853187, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8864]], camposKey:0006-8993 1990-01-01 Adaptation of in vitro rat-brain protein-synthesis to long-term ingestion of normal-butanol330332, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6942]], camposKey:0006-3592 1990-01-01 Changes in the activity of the general amino acid permease from Saccharomyces cerevisiae var. ellipsoideus during fermentation808810, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6938]], camposKey:0145-5680 1990-01-01 Differential d-glucose requirements of the general amino-acid permease and protein-synthesis in saccharomyces-cerevisiae var ellipsoideus581587, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6941]], camposKey:0145-5680 1990-01-01 Influence of the structure of alkanols on their inhibition of protein-synthesis in saccharomyces-cerevisiae var ellipsoideus337344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8865]], camposKey:0145-5680 1990-01-01 Messenger-dependent action of guanylylimidodiphosphate and translation inhibitors on rat-brain polypeptide-synthesis329335, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38511]], camposKey:0887-2333 1989-01-01 Effect of acute ethanol administration and nutritional-status on secretory protein-synthesis in isolated rat-liver cells712, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38510]], camposKey:0158-5231 1987-01-01 Polyvalent inhibitory-action of fusidic acid in isolated rat-liver cells10131019][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17799]},camposKey: 161 182 Development of Orthotopic and Spontaneous Metastatic Human Tumor Xenograft Models for Experimental Therapeutics 978-3-319-57423-3Patient-Derived Mouse Models of Cancer : Patient-Derived Orthotopic Xenografts (PDOX). 1 2017-01-01 Humana Press, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=2239]},camposKey: 139 179 Sensor arrays based on phthalocyanines: New developments on nanostructured and biomimetic electrochemical sensors 9814411159Multisensor Systems for Chemical Analysis 1 2014-02-21 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17797]},camposKey: 593 607 Metronomic Antiangiogenic Chemotherapy: Questions and Answers 978-3-540-33176Tumor angiogenesis : basic mechanisms and cancer therapy 1 2008-01-01 Springer, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17798]},camposKey: 277 296 Metronomic Low-Dose Antiangiogenic Chemotherapy in Mice and Man 978-1-58829-870-6Antiangiogenic agents in cancer therapy 1 2008-01-01 Humana Press, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=14834]},camposKey: 273 294 Toxins as Transporting Tools 3527308814Bacterial Toxins 1 2002-03-28 -][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626191]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372260][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bc587], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@466301], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413172], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412600], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f67], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4129da], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411bfe]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@143e0, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13fc5][]